Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC
ENTA — Enanta Pharmaceuticals, Inc.
N/A · Quality 0/100
Value Score 30 days ago: 2.9 → today 2.3
Price
11.6
Intrinsic value
-
no positive per-share earnings - the P/E-blend method needs a profit to value
Margin of safety
-
Implied growth (reverse DCF)
-
a described calculation from stated inputs, not a forecast
Value Score
2.3
Quality
0
Psychology
9.1
Discovery
16.8
price/volume attention only
Moat score
28
erosion: none
Value Score: bottom 8% of Russell 3000 · Quality: bottom 3%
Open the interactive Deep Dive for ENTA →
Use this data programmatically
This page's numbers are also available as JSON at /api/v1/deep-dive/ENTA - see the API docs for the full read-only surface, including an MCP server for AI assistants.
Common questions
What is Enanta Pharmaceuticals, Inc.'s Value Score?
Enanta Pharmaceuticals, Inc.'s Value Score is 2.3 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number. This is a described calculation from public data, not a recommendation.